Oct 12 (Reuters) - Spark Therapeutics Inc's experimental gene therapy for a rare form of blindness improves vision and should be approved, advisers to the Food and Drug Administration concluded on Thursday, paving the way for the first U.S. gene therapy for an inherited disease.


00


Reuters

Latest News

Reuters: Brent crude jumps above $65 for first time since 2015 after North Sea pipeline outage

CNN: Fires burn area size of NYC, Boston combined

BBC: UK snow: Ice warning as commuter disruption expected

USA Today: Fake fundraisers, racism allegations against mother follow Tennessee boy's anti-bullying video

USA Today: Fake fundraisers, racism allegations against mother follow Tennessee boy's anti-bullying video

Daily Mail: AFL WAG Clementine McVeigh shows off her Christmas shopping

Daily Mail: Rugby-Castle named Rugby Australia's first female chief

Daily Mail: Most China metals rise, buoyed by signs of industrial cuts

Daily Mail: Shorten blames Libs for Keneally rumour

Daily Mail: Ellie Goulding joins star-studded homeless charity concert

Daily Mail: Perth parents take swing down after busybody reports it

CTV News: U.S. federal appeals court considers kids' climate change lawsuit

Reuters: UPDATE 1-NZ's Fisher & Paykel sues Resmed in Australia over patent dispute

USA Today: Latest NYC terror attack shows how tough it is to stop a lone wolf

USA Today: Police: 2-year-old Utah girl killed by sibling in gun accident

USA Today: Dad frantically searches for missing son on Oregon streets

USA Today: Spirit boots breast-feeding woman from plane

USA Today: Fake fundraisers, racism allegations against mother follow Tennessee boy's anti-bullying video

CTV News: Protesters voice concerns with proposed changes to health care in N.B.

Haaretz: In Israel, punishing in order to silence

CNN: Comcast drops bid for 21st Century Fox assets

Daily Mail: Lindy Klim's fiance Adam Ellis dotes over newborn daughter

Daily Mail: Toddler pulls off EPIC bottle flip at family party!